What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
John T. Kissel focuses on Surgery, Pathology, Internal medicine, Spinal muscular atrophy and Muscle biopsy.
The Surgery study combines topics in areas such as Peripheral neuropathy, Anesthesia and Cohort.
His Pathology study combines topics in areas such as Ataxia, Intention tremor, Complement component 5 and Complement membrane attack complex.
His biological study spans a wide range of topics, including Gastroenterology and Chronic inflammatory demyelinating polyneuropathy.
Many of his research projects under Spinal muscular atrophy are closely connected to Nusinersen and Weight gain with Nusinersen and Weight gain, tying the diverse disciplines of science together.
His work focuses on many connections between Muscle biopsy and other disciplines, such as Vasculitis, that overlap with his field of interest in Superficial peroneal nerve and Angiopathy.
His most cited work include:
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy (758 citations)
- Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates (619 citations)
- Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria (480 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Physical therapy, Pathology, Spinal muscular atrophy and Clinical trial.
The concepts of his Internal medicine study are interwoven with issues in Surgery and Cardiology.
John T. Kissel works mostly in the field of Physical therapy, limiting it down to topics relating to Weakness and, in certain cases, Myotonia.
His work in the fields of SMN1 overlaps with other areas such as Nusinersen.
John T. Kissel usually deals with Clinical trial and limits it to topics linked to Natural history and Family medicine.
As a part of the same scientific family, John T. Kissel mostly works in the field of Randomized controlled trial, focusing on Myasthenia gravis and, on occasion, Eculizumab.
He most often published in these fields:
- Internal medicine (27.21%)
- Physical therapy (15.99%)
- Pathology (15.65%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (27.21%)
- Clinical trial (13.27%)
- Spinal muscular atrophy (13.61%)
In recent papers he was focusing on the following fields of study:
John T. Kissel mainly investigates Internal medicine, Clinical trial, Spinal muscular atrophy, Adverse effect and Physical medicine and rehabilitation.
His Internal medicine study integrates concerns from other disciplines, such as Chronic inflammatory demyelinating polyneuropathy and Cardiology.
His Clinical trial research is multidisciplinary, incorporating perspectives in Developmental Milestone, Family medicine, Respiratory care, Natural history and Muscular dystrophy.
John T. Kissel interconnects Compound muscle action potential, Intraclass correlation, Physical therapy and Rating scale in the investigation of issues within Spinal muscular atrophy.
His research integrates issues of Neuromuscular disease, Bimagrumab and Surgery in his study of Adverse effect.
The various areas that John T. Kissel examines in his Randomized controlled trial study include Prednisone and Thymectomy.
Between 2017 and 2021, his most popular works were:
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (117 citations)
- Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy (66 citations)
- Long-term safety and efficacy of eculizumab in generalized myasthenia gravis (56 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
John T. Kissel mostly deals with Internal medicine, Adverse effect, Spinal muscular atrophy, Randomized controlled trial and Pediatrics.
His Adverse effect research is multidisciplinary, incorporating perspectives in Anesthesia, Myotonic Disorder, Paramyotonia congenita and Ranolazine.
His studies deal with areas such as Choking, Compound muscle action potential, Physical therapy and Sitting as well as Spinal muscular atrophy.
His Randomized controlled trial study integrates concerns from other disciplines, such as Edrophonium, Absolute risk reduction, Prednisone and Thymectomy.
John T. Kissel interconnects Muscular dystrophy, Surgery and Intensive care medicine, Respiratory care in the investigation of issues within Clinical trial.
The study incorporates disciplines such as Chronic inflammatory demyelinating polyneuropathy, Carnitine, Valproic Acid and Polyradiculoneuropathy in addition to Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
